Iovance Biotherapeutics Inc (IOVA) — Net Asset Quality Index
Iovance Biotherapeutics Inc (IOVA) has a Net Asset Quality Index of 77.6% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $904.95 Million minus total liabilities of $202.66 Million yields net assets of $702.29 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read IOVA current and long-term liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Iovance Biotherapeutics Inc Net Asset Quality Index Over Time (2008–2024)
This chart shows how Iovance Biotherapeutics Inc's Net Asset Quality Index has evolved across 17 annual periods from 2008 to 2024. As of September 2025, the index stands at 77.6%, representing net assets of $702.29 Million against total assets of $904.95 Million USD. For live market cap and overall valuation, see how much is Iovance Biotherapeutics Inc worth.
Annual Net Asset Quality Index for Iovance Biotherapeutics Inc (2008–2024)
The table below presents the year-by-year Net Asset Quality Index for Iovance Biotherapeutics Inc from 2008 to 2024, covering 17 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check IOVA capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 78.0% | $710.40 Million | $910.43 Million | $200.02 Million | ▲ +3.1 pp |
| 2023 | 74.9% | $584.61 Million | $780.35 Million | $195.74 Million | ▼ -0.3 pp |
| 2022 | 75.2% | $499.64 Million | $663.98 Million | $164.34 Million | ▼ -4.7 pp |
| 2021 | 80.0% | $621.66 Million | $777.33 Million | $155.67 Million | ▼ -5.5 pp |
| 2020 | 85.4% | $656.50 Million | $768.46 Million | $111.96 Million | ▼ -1.3 pp |
| 2019 | 86.7% | $298.97 Million | $344.65 Million | $45.68 Million | ▼ -10.2 pp |
| 2018 | 97.0% | $466.19 Million | $480.82 Million | $14.63 Million | ▲ +3.3 pp |
| 2017 | 93.6% | $145.48 Million | $155.37 Million | $9.89 Million | ▼ -3.5 pp |
| 2016 | 97.1% | $166.92 Million | $171.89 Million | $4.97 Million | ▼ -1.3 pp |
| 2015 | 98.5% | $104.02 Million | $105.65 Million | $1.63 Million | ▲ +2.0 pp |
| 2014 | 96.4% | $44.85 Million | $46.51 Million | $1.66 Million | ▲ +7.8 pp |
| 2013 | 88.6% | $17.60 Million | $19.87 Million | $2.27 Million | ▲ +38573.2 pp |
| 2012 | -38484.6% | $-11.32 Million | $29.41K | $11.35 Million | ▼ -36236.1 pp |
| 2011 | -2248.5% | $-12.78 Million | $568.43K | $13.35 Million | ▼ -2292.1 pp |
| 2010 | 43.7% | $638.09K | $1.46 Million | $822.87K | ▲ +183.7 pp |
| 2009 | -140.0% | $-13.49K | $9.63K | $23.12K | ▼ -180.7 pp |
| 2008 | 40.7% | $2.28K | $5.61K | $3.33K | — |